Keyphrases
Lynch Syndrome
100%
Colorectal Cancer
62%
MLH1
24%
Mismatch Repair
23%
Colonoscopy
16%
Alzheimer's Disease
14%
MSH2
14%
Tumor
14%
MSH6
14%
Cancer Risk
13%
Pulmonary Metastasis
11%
Programmed Death-ligand 1 (PD-L1)
11%
Immune Cell Score
11%
Colorectal Carcinoma
11%
Pancreatic Cancer
11%
Colonoscopy Surveillance
10%
PMS2
10%
Colon Cancer
9%
Pathogenic Variants
9%
Prognostic Value
9%
Colorectal Cancer Incidence
9%
Microsatellite Instability-high (MSI-H)
9%
Microsatellite Stable Colorectal Cancer
8%
Population-based Study
8%
Cancer Incidence
8%
Hysterectomy
7%
Mismatch Repair Genes
7%
Phosphorylated tau
7%
Cerebrospinal Fluid Biomarkers
7%
Cancer-specific Survival
7%
Salpingo-oophorectomy
7%
Cerebrospinal Fluid
7%
Colorectal Cancer Risk
7%
Cancer Prevention
6%
Risk Reduction
6%
Endometrial Cancer
6%
Colorectal Adenoma
6%
Ovarian Cancer
6%
Brain Biopsy
6%
Primary Tumor
6%
Idiopathic Normal Pressure Hydrocephalus (iNPH)
6%
Hereditary Colorectal Cancer Syndromes
6%
Overall Survival
6%
5-year Survival
5%
Risk-reducing Surgery
5%
Randomized Placebo-controlled Trial
5%
Early Onset
5%
Screening Interval
5%
Multiplex Analysis
5%
Genetic Testing
5%
Medicine and Dentistry
Hereditary Nonpolyposis Colorectal Cancer
75%
Colorectal Cancer
72%
Malignant Neoplasm
29%
DNA Mismatch Repair
28%
Neoplasm
24%
Colonoscopy
21%
Lung Metastasis
14%
Immunocompetent Cell
14%
Colorectal Carcinoma
12%
Colon Cancer
11%
Cancer Incidence
11%
Cancer Risk
10%
Overall Survival
9%
Pancreas Cancer
9%
Metastatic Carcinoma
8%
Gene Repair
8%
Somatic Mutation
7%
Hysterectomy
7%
Disease
7%
Salpingooophorectomy
7%
Programmed Death-Ligand 1
7%
Rectum Cancer
7%
Carcinogenesis
7%
Surgery
6%
Endometrial Cancer
6%
Adenoma
6%
Cancer Staging
6%
Ovarian Cancer
6%
Cancer Prevention
6%
CD8 Antigen
6%
Acetylsalicylic Acid
6%
Colorectal Adenoma
6%
Primary Tumor
5%
Hereditary Colorectal Cancer
5%
Ulcerative Colitis
5%
Placebo
5%
Alzheimer's Disease
5%
Biological Marker
5%
